Physician

Andrew Peter Dalovisio, M.D.

According to 2025 Medicare claims, Andrew Dalovisio, M.D. (NPI: 1144458704) practices hematology/oncology in the Baton Rouge, LA market, with the plurality of this provider's patient population coming from E. Baton Rouge, LA. This provider's primary affiliated billing organization is MARY BIRD PERKINS CANCER CENTER (NPI: 1295833580; TIN: 237010520) and primary practice location at 70809-3482. Dalovisio is affiliated with the Ochsner Accountable Care Network, LLC (ACO ID: A1535), participating under the MSSP model.

Dalovisio's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 264 traditional Medicare patients, billed 1,260 HCPCS/CPT codes, and received $83,641 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,821 prescription claims across 281 beneficiaries totaling $13,312,163 in drug costs, led by Lenalidomide (Lenalidomide). 2020 DME data shows 13 claims. Open Payments data shows 59 records totaling $84,103. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $173,018 to $13,312,163. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.